Pharmaceutical company GlaxoSmithKline will donate 50 million doses of H1N1 vaccine to the World Health Organization (WHO). APA reports that the related agreement was signed in Geneva.
WHO Director-General Margaret Chan said WHO will work to see that these vaccines are distributed to those who need them.
GlaxoSmithKline expects to prepare the first shipments of vaccine to the WHO by the end of November. WHO has prepared a list of 95 developing countries that are slated for receiving vaccines from GSM, and it intends to cover 10 percent of the population in these countries.
Source: APA.Az
Pharmaceutical Process Equipment
